Cnbc Tv18 Ibla 2022

Serum Institute of India invested in Covishield -- the India-manufactured version of the Oxford-AstraZeneca vaccine against COVID-19 -- on an "at-risk" basis in March 2020, created regulatory hurdles and released the vaccine in a matter of nine months.

IBLA 2022 | 17th edition of India's Business Leader Awards underway

CNBC-TV18 hosted the 17th edition of India’s most coveted business awards, India Business Leader Awards (IBLA) 2022 on April 1 to honour the visionaries of Indian Inc. in the presence of Finance Minsiter Nirmala Sitharaman.

Indian Business Leader Awards: Ashwin Dani felicitated with Lifetime Achievement Award

The second-generation scion of Asian Paints, joined the company in 1968 as a senior executive and rose through the ranks to eventually lead it.

PharmEasy wins CNBC-TV18’s IBLA Young Turk of the Year Award

The young founders of PharmEasy are firmly in the ring, ready for the big fight that lies ahead in India’s e-healthcare space, where giants like Tata-backed 1mg, Apollo Hospital, Reliance-Netmed and Amazon, too, are in the game.